Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07345702

Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct

This multicenter retrospective registry study evaluates the safety and effectiveness of endovascular therapy versus medical therapy for acute large-core basilar artery occlusion. It also investigates clinical, imaging, and laboratory factors associated with functional outcomes and mortality. Patients are grouped according to the treatment received in routine clinical practice.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Xuanwu Hospital

Beijing, Beijing Municipality, 100053, China

Location status: Recruiting

Location contact

Chuanhui Li

CONTACT

[email protected]

15210439828

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years, men or women.
  • Occlusion (TIMI 0-1) of the basilar artery or intracranial segments of both vertebral arteries (V4) as evidenced by CTA/MRA/DSA.
  • Time from symptom onset (or last known well) to treatment (endovascular therapy or medical therapy) ≤7 days.
  • Patients with large core infarction in the posterior circulation, defined as a posterior circulation Acute Stroke Prognosis Early CT score (pc-ASPECTS) score of 0-5 on CT angiography source images or MR with diffusion-weighted imaging or non-contrast CT.

Exclusion criteria

  • Subjects with occlusions in both anterior and posterior circulation.
  • CT or MR evidence of hemorrhage (the presence of microbleeds on MRI is allowed).
  • Missing key clinical information (e.g., unavailable baseline NIHSS, unclear symptom onset/last known well time, or missing major treatment information including whether EVT was performed).
  • Baseline NIHSS score <6.
  • Woman of childbearing potential who is known to be pregnant or lactating or who has a positive pregnancy test on admission.
  • Missing follow-up outcomes at 90 days.
  • Any other condition judged by investigators to substantially affect analysis or interpretation.

Treatment and study plan

Endovascular therapy

Procedure

Endovascular therapy performed as part of routine clinical care for acute basilar artery occlusion, including mechanical thrombectomy with stent retriever and/or aspiration. Rescue angioplasty and/or intracranial stenting may be used at the operator's discretion. Peri-procedural management and concomitant medical therapy follow local standard practice.

Primary outcomes

  1. Proportion of Patients Achieving mRS 0-3 at 90 Days

    Time frame: 90 days

    The modified Rankin scale (range, 0 [no symptoms] to 6 [death]). Higher scores mean a worse outcome.

Secondary outcomes

  1. Ordinal Shift analysis of mRS at 90 days

    Time frame: 90 days

    The modified Rankin scale (range, 0 [no symptoms] to 6 [death])

  2. Rate of All-Cause Mortality at 90 Days

    Time frame: 90 days

    Death from any cause within 90 days.

  3. Rate of Symptomatic Intracranial Hemorrhage

    Time frame: 24 (-2/+12) hours

  4. Proportion of Patients Achieving mRS 0-3 at 1 year

    Time frame: 1 year

    The modified Rankin scale (range, 0 [no symptoms] to 6 [death]). Higher scores mean a worse outcome.

Study contacts

Contact information is provided by the study sponsor or research team.

Chuanhui Li

CONTACT

[email protected]

15210439828

Sponsors and collaborators

Lead sponsor

Xuanwu Hospital, Beijing

Other

Registry information

Official study title

Endovascular Versus Medical Therapy for Acute Large-Core Basilar Artery Occlusion: A Multicenter Retrospective Registry Study (BAOCHE-LC)

Acronym: BAOCHE-LC

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 16, 2026
Registry last updated
Jul 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.